Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up COVID-19: Information for Patients and Caregivers We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.What you need to know 1721 News Items found Three Memorial Sloan Kettering Cancer Center Faculty Members Elected as 2021 AAAS Fellows Thursday, January 27, 2022 Three faculty members from Memorial Sloan Kettering Cancer Center (MSK) and Sloan Kettering Institute (SKI) have been elected to the 2021 class of American Association for the Advancement of Science (AAAS) Fellows. Craig B. Thompson Named to City & State’s 2022 Health Care Power 100 List Wednesday, January 26, 2022 Craig B. Thompson, MD, President and CEO of Memorial Sloan Kettering Cancer Center (MSK), has been named to City & State’s 2022 Health Care Power 100 list. New MSK Radiation Approach Means Fewer Side Effects for More Patients with HPV-Related Head and Neck Cancer Thursday, January 20, 2022 A low-dose radiation approach could help more patients avoid side effects of treatment for head and neck cancer. A New Immunotherapy Discovery: Putting a HIT on Elusive Cancer Cells Wednesday, January 19, 2022 A new type of engineered immune cell could be a potent treatment for cancers that have escaped other immunotherapies. In the Lab Why Do Brain Tumors Often Return After Treatment? MSK Researchers Say Stem Cells May Be Key Tuesday, January 11, 2022 In a new study, MSK researchers looked at why glioblastoma brain tumors usually come back after treatment. Their findings suggest that a subset of cells — cancer stem cells — are able to evade current treatments because they are not actively dividing, and that these cells later form new tumors. Clinical Trial for Beta-Thalassemia Brings Important Insights for Treating Blood Disorders with Stem Cell Gene Therapy Thursday, January 6, 2022 A gene therapy approach could prove effective at treating an inherited blood disorder called beta (β)-thalassemia. Feature How a Mishap in Early Development Can Lead to a Lifetime of Cancer Risk Wednesday, January 5, 2022 MSK researchers have found mutations that arise in embryos can convey a risk of cancer that’s similar to what’s seen in people with inherited cancer mutations. New Research Shows the HPV Cancer Vaccine Saves Lives Monday, January 3, 2022 Learn why MSK recommends that children be vaccinated against HPV. From Breaks to Breakthroughs Saturday, January 1, 2022 Maria Jasin’s discoveries have led to concrete advances in patient care. The targeted medicines called PARP inhibitors, for example, are based on knowledge gained from her work. Looking for Patterns in Cancer Survivors Saturday, January 1, 2022 Cancer treatment is complex. For every type of cancer, there is a range of treatments, side effects, and outcomes. Machine learning can help make sense of these variables, according to Quaid Morris. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cody's Story: How the MSK Kids Rare Tumor Program Benefited a Teenager With Advanced Kidney Cancer